Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidi Chen

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Cell Metabolism|March 11, 2022
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapyLupeng Ye, Jonathan J Park, Lei Peng, et al.
Nature Reviews. Methods Primers|May 22, 2023
High-content CRISPR screeningChristoph Bock, Paul Datlinger, Florence Chardon, et al.
Cell|September 30, 2014
CRISPR-Cas9 knockin mice for genome editing and cancer modelingRandall J Platt, Sidi Chen, Yang Zhou, et al.
Cell|August 24, 2019
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T CellsMatthew B Dong, Guangchuan Wang, Ryan D Chow, et al.
Nature|February 25, 2026
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumoursLuojia Yang, Paul A Renauer, Kaiyuan Tang, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617Lei Peng, Yingxia Hu, Madeleine C Mankowski, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman SyndromeXiaona Lu, Ying Xie, Youmei Bao, et al.
Nature|September 25, 2024
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remissionZhiliang Bai, Bing Feng, Susan E McClory, et al.
Nature Communications|March 29, 2022
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617Lei Peng, Yingxia Hu, Madeleine C Mankowski, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Spatially Resolved <i>in vivo</i> CRISPR Screen Sequencing via Perturb-DBiTAlev Baysoy, Xiaolong Tian, Feifei Zhang, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Cell Metabolism|March 11, 2022
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapyLupeng Ye, Jonathan J Park, Lei Peng, et al.
Nature Reviews. Methods Primers|May 22, 2023
High-content CRISPR screeningChristoph Bock, Paul Datlinger, Florence Chardon, et al.
Cell|September 30, 2014
CRISPR-Cas9 knockin mice for genome editing and cancer modelingRandall J Platt, Sidi Chen, Yang Zhou, et al.
Cell|August 24, 2019
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T CellsMatthew B Dong, Guangchuan Wang, Ryan D Chow, et al.
Nature|February 25, 2026
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumoursLuojia Yang, Paul A Renauer, Kaiyuan Tang, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617Lei Peng, Yingxia Hu, Madeleine C Mankowski, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman SyndromeXiaona Lu, Ying Xie, Youmei Bao, et al.
Nature|September 25, 2024
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remissionZhiliang Bai, Bing Feng, Susan E McClory, et al.
Nature Communications|March 29, 2022
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617Lei Peng, Yingxia Hu, Madeleine C Mankowski, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Spatially Resolved <i>in vivo</i> CRISPR Screen Sequencing via Perturb-DBiTAlev Baysoy, Xiaolong Tian, Feifei Zhang, et al.
Pageof 13